David B. Dix, MD | Authors

Regimen Improved Survival in Children With High-Risk Wilms Tumors

June 05, 2015

In this video, Dr. Dix, discusses the results of two phase III trials that showed that in children with high-risk Wilms tumor, treatment with vincristine and dactinomycin plus the addition of doxorubicin improved outcomes.